
Sign up to save your podcasts
Or


The Pfizer-BioNTech and Moderna COVID-19 mRNA vaccines are the first of many being tested for widespread use. Buddy Creech, MD, MPH, director of the Vanderbilt Vaccine Research Program, reviews these and other vaccines likely to become available, including products that use inactivated, protein subunit, and viral vector immunization strategies.
Related Content:
SARS-CoV-2 Vaccines
By JAMA Network4.4
472472 ratings
The Pfizer-BioNTech and Moderna COVID-19 mRNA vaccines are the first of many being tested for widespread use. Buddy Creech, MD, MPH, director of the Vanderbilt Vaccine Research Program, reviews these and other vaccines likely to become available, including products that use inactivated, protein subunit, and viral vector immunization strategies.
Related Content:
SARS-CoV-2 Vaccines

321 Listeners

549 Listeners

701 Listeners

163 Listeners

260 Listeners

906 Listeners

3,374 Listeners

38 Listeners

21 Listeners

16 Listeners

11 Listeners

8 Listeners

17 Listeners

19 Listeners

5 Listeners

6 Listeners

1,150 Listeners

31 Listeners

9 Listeners

94 Listeners

141 Listeners

14 Listeners

5 Listeners

518 Listeners

5 Listeners

367 Listeners

260 Listeners

437 Listeners

106 Listeners

18 Listeners

320 Listeners

2 Listeners

325 Listeners

270 Listeners